Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2026-03-04

Clinical Trial Update: LRFN5 and OLFM4 in Schizoaffective Disorder

View source ↗

Summary

Clinical trial update indicates a study examining LRFN5 and OLFM4 in schizoaffective disorder, with status NOT_YET_RECRUITING at Elazığ Mental Health and Diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Elazığ Mental Health and Diseases Hospital | Conditions: Schizoaffective Disorder | Status: NOT_YET_RECRUITING